INBX Earnings Date: Nov 13, 2026 (Estimated) — Inhibrx Biosciences Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is INBX's next earnings date?
Inhibrx Biosciences Inc. (INBX) is expected to report Q3 2026 earnings on Friday, November 13, 2026 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$2.45 on revenue of $1.9M.
How did INBX do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Inhibrx Biosciences Inc. posted EPS of -$2.34 versus the -$2.28 estimate, a miss of 0.9%. Revenue was $0. The stock's 1-day post-earnings move was -8.9%.
How much does INBX stock move after earnings?
INBX beat EPS estimates in 4 of its last 7 reported quarters. Over the last 8 reports the stock moved an average of 4.1% (up or down) in the day after earnings.
About Inhibrx Biosciences Inc.
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -2.28 | -2.34 | -0.86% | $0 | ❌ Miss | -8.91% | +2.21% | +13.87% |
| 2026-05-14 | Q1 2026 | -1.43 | -2.15 | -50.35% | $0 | ❌ Miss | -6.47% | -4.81% | -19.50% |
| 2026-03-19 | Q4 2025 | -2.45 | -2.11 | +13.88% | $0 | ✅ Beat | -6.09% | +1.42% | +27.00% |
| 2025-11-14 | Q3 2025 | -2.21 | -2.28 | -3.17% | $0 | ❌ Miss | +6.04% | +7.00% | +2.13% |
| 2025-08-13 | Q2 2025 | -2.73 | -1.85 | +32.23% | $1.3M | ✅ Beat | +1.57% | +3.56% | +16.76% |
| 2025-03-17 | Q4 2024 | — | -3.09 | — | $100,000 | — | +0.43% | +5.60% | -15.42% |
| 2024-11-14 | Q3 2024 | -3.38 | -2.84 | +15.98% | $0 | ✅ Beat | -3.49% | -2.44% | +1.60% |
| 2024-08-13 | Q2 2024 | -1.47 | 125.48 | +8636.05% | $100,000 | ✅ Beat | -0.09% | +14.25% | +33.45% |
Showing last 8 quarters.